Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers
PaperCitations, authors & open-access status
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 104 citations, 2022 year and bronze oa status.
104
Citations
2022
Year
bronze
OA Status